Catalyst Pharmaceuticals Inc (CPRX)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	219,329	192,017	240,968	198,911	320,806	276,310	242,558	221,191	210,106	192,795	176,305	161,533	159,244	143,342	131,164	116,944	111,364	90,579	72,056	54,862
Total current liabilities	US$ in thousands	76,063	57,806	52,503	56,709	57,588	44,681	22,488	22,938	27,063	20,614	16,135	14,436	22,756	18,232	20,210	17,636	24,099	17,982	14,152	9,026
Current ratio		2.88	3.32	4.59	3.51	5.57	6.18	10.79	9.64	7.76	9.35	10.93	11.19	7.00	7.86	6.49	6.63	4.62	5.04	5.09	6.08

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $219,329K ÷ $76,063K
= 2.88

The current ratio of Catalyst Pharmaceuticals Inc has exhibited fluctuations over the past few years, ranging from a low of 2.88 to a high of 11.19. The company's current ratio provides insight into its ability to cover short-term obligations with its current assets. A higher current ratio generally indicates a better ability to pay off short-term liabilities.

Looking at the trend, the current ratio has generally been on an upward trajectory, reaching its peak in the most recent quarter at 11.19. This suggests that the company has significantly improved its short-term liquidity position. However, the sharp increase from the previous quarter's ratio of 3.51 to 11.19 should be further investigated to understand the underlying reasons for such a substantial change.

Overall, the current ratio of Catalyst Pharmaceuticals Inc reflects a strong liquidity position in recent quarters, indicating the company's ability to meet its short-term obligations comfortably.